Paasa Logo
Alvotech logo
ALVONASDAQMarket closedOpens 9:30am ET

Alvotech

$6.15Last updated
+$0.40 (6.96%)Past day
Timezone

Alvotech (NASDAQ: ALVO) is trading at $6.15, about ₹591 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, up 6.96% today. Indian residents can buy Alvotech from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$5.73
Previous close:$5.75
Volume:1.43M

Today's low

$5.71

Today's high

$6.15

52 week low

$2.94

52 week high

$9.05

ALVO opened at $5.73, closed previously at $5.75, and has traded between $2.94 and $9.05 over the past 52 weeks.

About

Alvotech, along with its various subsidiaries, is dedicated to the global development and manufacturing of biosimilar pharmaceuticals. Its product offerings span key therapeutic categories, encompassing autoimmune conditions, eye disorders, bone diseases, and cancer. A flagship program for the company is AVT02, a high-concentration biosimilar equivalent to Humira. This candidate is designed to address a range of inflammatory illnesses, including rheumatoid arthritis, psoriatic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis. Similarly, AVT04 is a biosimilar version of Stelara, targeting inflammatory conditions such as psoriatic arthritis, Crohn's disease, ulcerative colitis, and plaque psoriasis. For ophthalmic conditions, AVT06 serves as a biosimilar to Eylea, intended for the treatment of age-related macular degeneration, macular edema, and diabetic retinopathy. Currently in preclinical stages, AVT03 is a biosimilar to Xgeva and Prolia, with the goal of preventing bone fractures, alleviating spinal cord compression, reducing the necessity for radiation or bone surgery in certain cancer patients, and both preventing bone loss and increasing bone density. Additionally, Alvotech's pipeline features AVT05, an early-stage biosimilar for Simponi and Simponi Aria, which is being developed for various inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. Other promising candidates include AVT16, an immunology biosimilar; AVT23, a late-stage biosimilar to Xolair, aimed at treating nasal polyps; and AVT33, an oncology biosimilar. Established in 2013, Alvotech maintains its primary corporate headquarters in Reykjavik, Iceland.

Country
LU
CEO
Lisa Graver
Exchange listed on
NASDAQ
Industry
Drug Manufacturers - Specialty & Generic
Base currency
USD
Full Time Employees
1,279
Sector
Healthcare
IPO date
16/06/2022

Key statistics

Avg. volume

986.84K

Market cap

$2.08B

P/E Ratio

-10.53

Price-to-sales ratio

4.23

Enterprise value

$3.39B

Free cash flow yield

-14.43%

Debt-to-equity ratio

-7.58

Return on equity

76.83%

ROIC

3.61%

Beta

0.18

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$586.32M

Earnings per share

$0.10

Free cash flow

-$114.67M

Net profit margin

-36.51%

Gross margin

60.45%

EBITDA

$323.39M

Revenue growth

19.74%

Similar securities

This is not an investment recommendation

How to buy Alvotech from India

Indian residents can buy Alvotech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Alvotech and place an order

    Find Alvotech by name or by its ticker, ALVO, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Alvotech trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Alvotech position in USD and INR. Alvotech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Alvotech from India

Trading and taxes when buying Alvotech from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneAlvotech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Alvotech stock?

Yes. Alvotech (ALVO) has been listed on NASDAQ since 2022, in the Drug Manufacturers - Specialty & Generic industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Alvotech share cost in rupees?

One Alvotech share is $6.15 — about ₹591 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the Alvotech price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Alvotech from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Alvotech?

Yes. One Alvotech share is $6.15, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Alvotech.

How are gains on Alvotech shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Alvotech price. Paasa issues a capital-gains statement for your return.

Does Alvotech pay a dividend?

No. Alvotech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Alvotech from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is Alvotech a United States company, and does that change how it is taxed?

Alvotech trades on NASDAQ in US dollars, but the company is domiciled in Luxembourg. Alvotech trades as an ordinary share listed directly in the US, not a depositary receipt. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare Alvotech shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Alvotech holding, its cost and its closing value.

How do I sell Alvotech and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.